Perrigo Basic EPS 2010-2024 | PRGO

Perrigo basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
Perrigo Annual Basic EPS
2024 $-1.25
2023 $-0.09
2022 $-1.04
2021 $-0.52
2020 $-1.20
2019 $1.07
2018 $0.95
2017 $0.84
2016 $-28.01
2015 $0.29
2015 $0.97
2014 $2.02
2013 $4.71
2012 $4.31
2011 $3.67
2010 $2.45
2009 $1.58
Perrigo Quarterly Basic EPS
2024-12-31 $-0.32
2024-09-30 $-0.15
2024-06-30 $-0.79
2024-03-31 $0.01
2023-12-31 $-0.23
2023-09-30 $0.10
2023-06-30 $0.06
2023-03-31 $-0.02
2022-12-31 $-0.17
2022-09-30 $-0.37
2022-06-30 $-0.48
2022-03-31 $-0.02
2021-12-31 $0.06
2021-09-30 $-0.44
2021-06-30 $-0.43
2021-03-31 $0.29
2020-12-31 $-1.29
2020-09-30 $-1.13
2020-06-30 $0.44
2020-03-31 $0.78
2019-12-31 $-0.15
2019-09-30 $0.68
2019-06-30 $0.07
2019-03-31 $0.47
2018-12-31 $0.61
2018-09-30 $-0.49
2018-06-30 $0.26
2018-03-31 $0.57
2017-12-31 $0.52
2017-09-30 $0.31
2017-06-30 $-0.49
2017-03-31 $0.50
2016-12-31 $-9.48
2016-09-30 $-11.10
2016-06-30 $-3.73
2016-03-31 $-3.70
2015-12-31 $-1.18
2015-09-30 $1.78
2015-06-30 $-0.15
2015-03-31 $-0.16
2014-12-31 $0.52
2014-09-30 $0.72
2014-06-30
2014-03-31 $0.36
2013-12-31 $-0.87
2013-09-30 $1.18
2013-06-30
2013-03-31 $1.19
2012-12-31 $1.13
2012-09-30 $1.13
2012-06-30
2012-03-31 $1.24
2011-12-31 $1.07
2011-09-30 $0.76
2011-06-30
2011-03-31 $0.96
2010-12-31 $0.98
2010-09-30 $0.81
2010-06-30
2010-03-31 $0.68
2009-12-31 $0.66
2009-09-30 $0.56
2009-06-30
2009-03-31 $0.50
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.455B $4.373B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $227.162B 27.40
Boston Scientific (BSX) United States $140.689B 37.90
Stryker (SYK) United States $132.255B 28.42
EssilorLuxottica (ESLOY) France $128.431B 0.00
Medtronic (MDT) Ireland $105.938B 15.47
Lonza Group Ag (LZAGY) Switzerland $47.424B 0.00
Haleon (HLN) United Kingdom $46.151B 26.20
ResMed (RMD) United States $31.269B 24.08
Agilent Technologies (A) United States $29.217B 19.30
GE HealthCare Technologies (GEHC) United States $28.556B 13.89
Terumo (TRUMY) Japan $28.160B 0.00
Koninklijke Philips (PHG) Netherlands $22.192B 15.85
Zimmer Biomet Holdings (ZBH) United States $19.373B 12.24
Insulet (PODD) United States $17.332B 74.11
Baxter (BAX) United States $14.818B 10.66
Smith & Nephew SNATS (SNN) United Kingdom $11.356B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Lantheus Holdings (LNTH) United States $6.938B 17.06
Bio-Rad Laboratories (BIO) United States $6.672B 23.10
Demant (WILYY) Denmark $6.644B 0.00
Prestige Consumer Healthcare (PBH) United States $3.977B 18.98
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.400B 29.07
Haemonetics (HAE) United States $2.872B 13.52
Envista Holdings (NVST) United States $2.614B 20.80
GN Store Nord (GNNDY) Denmark $2.188B 14.75
LeMaitre Vascular (LMAT) United States $1.946B 44.47
QuidelOrtho (QDEL) United States $1.698B 14.22
AtriCure (ATRC) United States $1.565B 0.00
Kestra Medical Technologies (KMTS) United States $1.214B 0.00
Green Thumb Industries (GTBIF) United States $1.189B 18.67
AdaptHealth (AHCO) United States $1.051B 10.12
BioLife Solutions (BLFS) United States $1.041B 0.00
InMode (INMD) Israel $1.038B 8.67
Neogen (NEOG) United States $0.953B 12.19
Phibro Animal Health (PAHC) United States $0.700B 10.74
Evolus (EOLS) United States $0.686B 0.00
Curaleaf Holdings (CURLF) Canada $0.649B 0.00
Valneva SE (VALN) France $0.552B 0.00
Owens & Minor (OMI) United States $0.535B 4.56
CeriBell (CBLL) United States $0.532B 0.00
Capricor Therapeutics (CAPR) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.450B 0.00
Surmodics (SRDX) United States $0.394B 0.00
Omeros (OMER) United States $0.394B 0.00
SNDL (SNDL) Canada $0.368B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Cresco Labs (CRLBF) United States $0.328B 0.00
VAREX IMAGING (VREX) United States $0.302B 13.07
Viemed Healthcare (VMD) United States $0.262B 23.68
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 15.65
Sanuwave Health (SNWV) United States $0.256B 0.00
Verano Holdings (VRNOF) United States $0.251B 0.00
Aurora Cannabis (ACB) Canada $0.250B 44.40
Cerus (CERS) United States $0.242B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Quanterix (QTRX) United States $0.200B 0.00
Canopy Growth (CGC) Canada $0.189B 0.00
High Tide (HITI) Canada $0.187B 0.00
Biote (BTMD) United States $0.181B 4.12
TriSalus Life Sciences (TLSI) United States $0.175B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.24
Brainsway (BWAY) Israel $0.155B 48.47
Jin Medical (ZJYL) China $0.147B 0.00
Organigram Global (OGI) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.123B 15.42
Agape ATP (ATPC) $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.086B 0.00
TerrAscend (TSNDF) Canada $0.083B 0.00
Exagen (XGN) United States $0.080B 0.00
MacroGenics (MGNX) United States $0.079B 0.00
Veru (VERU) United States $0.078B 0.00
Fonar (FONR) United States $0.076B 10.65
Zynex (ZYXI) United States $0.066B 24.22
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.063B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
United-Guardian (UG) United States $0.038B 11.61
Apyx Medical (APYX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.036B 0.00
Rockwell Medical (RMTI) United States $0.035B 51.50
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.010B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00